Karo Pharma AB buy Morgan Stanley
Start price
26.06.25
/
50%
€5.44
Target price
26.06.26
€45.35
Performance (%)
-
End price
27.06.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Karo Pharma AB | - | - | - |
| iShares Core DAX® | 2,57 % | 3,50 % | 8,41 % |
| iShares Nasdaq 100 | 4,86 % | 0,65 % | 28,38 % |
| iShares Nikkei 225® | 5,59 % | -0,25 % | 52,92 % |
| iShares S&P 500 | 3,25 % | 2,08 % | 24,37 % |
Comments by Morgan_Stanley for this prediction
In the thread Karo Pharma AB diskutieren
Karooooo Ltd. (NASDAQ: KARO) had its price target raised by analysts at Morgan Stanley from $43.00 to $53.00. They now have an "overweight" rating on the stock.
Ratings data for KARO provided by MarketBeat
In the thread Trading Karo Pharma AB
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten